Publication | Open Access

Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience

Checkpoint InhibitionUrologyMetastatic Urothelial CancerGenitourinary CancerImmunologyImmune Checkpoint InhibitorFibroblast Growth FactorReal World ExperienceMedicineTumor Microenvironment